OrbiMed’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $61.6M | Buy |
1,059,971
+612,771
| +137% | +$28.2M | 1.34% | 23 |
|
|
2025
Q4 | $20M | Buy |
447,200
+27,600
| +7% | +$1.16M | 0.41% | 62 |
|
|
2025
Q3 | $16.8M | Sell |
419,600
-528,277
| -56% | -$18.6M | 0.4% | 58 |
|
|
2025
Q2 | $29.7M | Hold |
947,877
| – | – | 0.75% | 34 |
|
|
2025
Q1 | $31.8M | Hold |
947,877
| – | – | 0.76% | 36 |
|
|
2024
Q4 | $37.2M | Buy |
947,877
+36,457
| +4% | +$1.51M | 0.77% | 38 |
|
|
2024
Q3 | $35.9M | Buy |
911,420
+49,058
| +6% | +$1.98M | 0.66% | 45 |
|
|
2024
Q2 | $33.6M | Buy |
862,362
+312,362
| +57% | +$12.5M | 0.67% | 44 |
|
|
2024
Q1 | $23.7M | Hold |
550,000
| – | – | 0.43% | 59 |
|
|
2023
Q4 | $25.3M | Sell |
550,000
-408,793
| -43% | -$14.4M | 0.51% | 57 |
|
|
2023
Q3 | $32.8M | Sell |
958,793
-137,207
| -13% | -$5.13M | 0.7% | 54 |
|
|
2023
Q2 | $42.2M | Sell |
1,096,000
-53,100
| -5% | -$2.11M | 0.77% | 46 |
|
|
2023
Q1 | $41.1M | Hold |
1,149,100
| – | – | 0.81% | 42 |
|
|
2022
Q4 | $45.3M | Buy |
1,149,100
+11,800
| +1% | +$430K | 0.87% | 44 |
|
|
2022
Q3 | $41.1K | Sell |
1,137,300
-191,900
| -14% | -$6.9M | 0.76% | 49 |
|
|
2022
Q2 | $40.4K | Buy |
1,329,200
+643,200
| +94% | +$19.5M | 0.74% | 45 |
|
|
2022
Q1 | $21M | Buy |
686,000
+55,000
| +9% | +$1.65M | 0.34% | 65 |
|
|
2021
Q4 | $19.7M | Buy |
631,000
+154,000
| +32% | +$4.6M | 0.25% | 85 |
|
|
2021
Q3 | $7.29M | Sell |
477,000
-857,217
| -64% | -$14.9M | 0.08% | 142 |
|
|
2021
Q2 | $24.8M | Sell |
1,334,217
-1,163,700
| -47% | -$21.5M | 0.25% | 89 |
|
|
2021
Q1 | $44.7M | Hold |
2,497,917
| – | – | 0.42% | 67 |
|
|
2020
Q4 | $38.4M | Hold |
2,497,917
| – | – | 0.34% | 72 |
|
|
2020
Q3 | $27.7M | Hold |
2,497,917
| – | – | 0.35% | 73 |
|
|
2020
Q2 | $31.3M | Buy |
2,497,917
+835,105
| +50% | +$10.6M | 0.44% | 63 |
|
|
2020
Q1 | $18.9M | Buy |
1,662,812
+1,028,000
| +162% | +$14.6M | 0.32% | 69 |
|
|
2019
Q4 | $8.32M | Hold |
634,812
| – | – | 0.12% | 86 |
|
|
2019
Q3 | $5.72M | Hold |
634,812
| – | – | 0.11% | 89 |
|
|
2019
Q2 | $6.26M | Hold |
634,812
| – | – | 0.1% | 105 |
|
|
2019
Q1 | $6.45M | Hold |
634,812
| – | – | 0.1% | 102 |
|
|
2018
Q4 | $4.01M | Hold |
634,812
| – | – | 0.07% | 108 |
|
|
2018
Q3 | $8.38M | Hold |
634,812
| – | – | 0.1% | 116 |
|
|
2018
Q2 | $5.84M | Hold |
634,812
| – | – | 0.07% | 126 |
|
|
2018
Q1 | $3.11M | Hold |
634,812
| – | – | 0.04% | 128 |
|
|
2017
Q4 | $1.79M | Hold |
634,812
| – | – | 0.02% | 123 |
|
|
2017
Q3 | $1.87M | Hold |
634,812
| – | – | 0.02% | 131 |
|
|
2017
Q2 | $2M | Hold |
634,812
| – | – | 0.02% | 128 |
|
|
2017
Q1 | $2.54M | Sell |
634,812
-365,188
| -37% | -$2.87M | 0.03% | 124 |
|
|
2016
Q4 | $7.7M | Hold |
1,000,000
| – | – | 0.1% | 99 |
|
|
2016
Q3 | $8.1M | Buy |
+1,000,000
| New | +$7.72M | 0.09% | 110 |
|
Other funds holding XENE
ACA
DCM
PCH
